| Copper | Approved Investigational | APCDD1L | 164284 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of APCDD1L mRNA | 20q13.32 | |
| Copper | Approved Investigational | APEH | 327 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of APEH mRNA | 3p21.31 | |
| Copper | Approved Investigational | APOC1 | 341 |
downregulated | Copper results in decreased expression of APOC1 mRNA | 19q13.32 | |
| Copper | Approved Investigational | APOM | 55937 |
downregulated | Copper results in decreased expression of APOM mRNA | 6p21.33 | |
| Copper | Approved Investigational | APP | 351 |
downregulated | Copper deficiency results in decreased expression of APP mRNA | 21q21.3 | |
| Copper | Approved Investigational | APP | 351 |
upregulated | Copper results in increased expression of APP mRNA | 21q21.3 | |
| Copper | Approved Investigational | APP | 351 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of APP mRNA | 21q21.3 | |
| Copper | Approved Investigational | APPL1 | 26060 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of APPL1 mRNA | 3p14.3 | |
| Copper | Approved Investigational | AQP11 | 282679 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of AQP11 mRNA | 11q14.1 | |
| Copper | Approved Investigational | AQP3 | 360 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of AQP3 mRNA | 9p13.3 | |
| Copper | Approved Investigational | ARC | 23237 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ARC mRNA | 8q24.3 | |
| Copper | Approved Investigational | ARC | 23237 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ARC mRNA | 8q24.3 | |
| Copper | Approved Investigational | ARF1 | 375 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ARF1 mRNA | 1q42.13 | |
| Copper | Approved Investigational | ARHGAP11A | 9824 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ARHGAP11A mRNA | 15q13.3 | |
| Copper | Approved Investigational | ARHGAP22 | 58504 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ARHGAP22 mRNA | 10q11.22-q11.23 | |
| Copper | Approved Investigational | ARHGAP26 | 23092 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ARHGAP26 mRNA | 5q31.3 | |
| Copper | Approved Investigational | ARHGAP32 | 9743 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ARHGAP32 mRNA | 11q24.3 | |
| Copper | Approved Investigational | ARHGEF2 | 9181 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ARHGEF2 mRNA | 1q22 | |
| Copper | Approved Investigational | ARHGEF26 | 26084 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ARHGEF26 mRNA | 3q25.2 | |
| Copper | Approved Investigational | ARHGEF28 | 64283 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ARHGEF28 mRNA | 5q13.2 | |
| Copper | Approved Investigational | ARL5B | 221079 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ARL5B mRNA | 10p12.31 | |
| Copper | Approved Investigational | ARL8B | 55207 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ARL8B mRNA | 3p26.1 | |
| Copper | Approved Investigational | ARMC10 | 83787 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ARMC10 mRNA | 7q22.1 | |
| Copper | Approved Investigational | ARMC6 | 93436 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ARMC6 mRNA | 19p13.11 | |
| Copper | Approved Investigational | ARMC9 | 80210 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ARMC9 mRNA | 2q37.1 | |